問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-03-01 - 2027-02-28
Condition/Disease
Test Drug
Participate Sites16Sites
Recruiting16Sites
2021-01-04 - 2026-03-31
Participate Sites6Sites
Recruiting6Sites
2022-04-01 - 2028-02-28
Participate Sites5Sites
Recruiting5Sites
2024-05-01 - 2028-12-31
2023-08-01 - 2027-04-01
Participate Sites3Sites
Recruiting3Sites
2024-10-24 - 2027-07-15
Participate Sites4Sites
Recruiting4Sites
2020-03-01 - 2026-12-31
Participate Sites2Sites
Recruiting2Sites
2021-12-01 - 2025-07-31
Terminated3Sites
2023-03-01 - 2027-04-30
Atherosclerotic Cardiovascular Disease
olpasiran (AMG 890)
Participate Sites10Sites
Recruiting9Sites
Terminated1Sites
Division of General Internal Medicine
2021-04-01 - 2028-12-31
全部
